Drug
UB Vv500
UB Vv500: highest development phase Phase 1, developed by Umoja Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Umoja Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| UB-VV500 NCT07735546 | Phase 1 | Multiple Myeloma in Relapse |
Latest
No recent events.
Follow UB Vv500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.